Last reviewed · How we verify

NCT06598475

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Recruiting now NA Last updated 10 April 2025
What this trial tests

NA trial testing Facilitator-driven provider- and practice-level implementation strategies for influencing provider recommendations and practice-level HPV vaccination rates in Human Papillomavirus Infection in 2,142 participants. Currently enrolling.

Timeline
13 March 2025
Primary endpoint
1 February 2028
1 August 2028

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment2,142
Start date13 March 2025
Primary completion1 February 2028
Estimated completion1 August 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 11 to 17, any sex, with Human Papillomavirus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Trusted health system implementation strategies to increase vaccination (TRUE SYNERGI): a stepped-wedge cluster randomized trial to reduce HPV-related cancers.
    Morales-Campos DY, Adsul P, Liang Y, Donovan E, et al · · 2025 · PMID 40205591 · DOI 10.1186/s12889-025-22273-7

Verify or expand the search:

Other recruiting trials for Human Papillomavirus Infection

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06598475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing